Newsletter - Banner

Breadcrumb

What's New at the RI-MUHC?

Asset Publisher

Study identifies strategies to reduce breast cancer growth and related skeletal lesions

RI-MUHC team publishes findings in the journal, Bone Research

Early treatment trial of hydroxychloroquine shows no symptomatic benefit for COVID-19 patients

Adult outpatients with mild symptoms of COVID-19 don’t benefit from taking hydroxychloroquine

Sodium found to regulate the biological clock of mice

New study by RI-MUHC researchers first to establish that physiological signals influence circadian rhythms

See more news - RI-MUHC Live

Research Life

Asset Publisher

Canada Research Chairs Program announces new and renewed chairs

Congratulations to five RI-MUHC researchers!

Dr. Armen Aprikian appointed Clinical Lead, Rossy Cancer Network

A leading urologic oncologist and researcher takes the helm

Charles Bourque named President of the Canadian Association for Neuroscience

RI-MUHC researcher’s career is dedicated to advancing brain research

Dr. Thomas Emmett Francoeur awarded the Prix Letondal

Pioneering work in child development recognized by the Association of Pediatricians of Quebec

See more news- Research Life

Close Up

Asset Publisher

Reaching beyond the hallowed halls of academe

“With science under attack, scientists have little choice but to step into the limelight and fight for what matters most” – Dr. Madhukar Pai

See More News - Close Up